Walleye Trading
MYGN icon

Walleye Trading’s Myriad Genetics MYGN Stock Holding History

Walleye Trading’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-800
Closed -$22K – 5699
2021
Q4 		$22K Buy
+800
New +$23.2K ﹤0.01% 4899
2021
Q1 		– Sell
-13,700
Closed -$271K – 5121
2020
Q4 		$271K Buy
13,700
+11,200
+448% +$181K ﹤0.01% 3243
2020
Q3 		$33K Sell
2,500
-11,900
-83% -$151K ﹤0.01% 3739
2020
Q2 		$163K Sell
14,400
-48,600
-77% -$690K ﹤0.01% 3217
2020
Q1 		$902K Buy
63,000
+11,300
+22% +$239K 0.01% 1375
2019
Q4 		$1.41M Buy
51,700
+41,900
+428% +$1.15M 0.01% 1504
2019
Q3 		$281K Buy
9,800
+3,800
+63% +$111K ﹤0.01% 2651
2019
Q2 		$167K Sell
6,000
-5,500
-48% -$155K ﹤0.01% 3065
2019
Q1 		$382K Sell
11,500
-25,000
-68% -$761K ﹤0.01% 2488
2018
Q4 		$1.06M Buy
36,500
+20,000
+121% +$719K 0.01% 1649
2018
Q3 		$759K Sell
16,500
-700
-4% -$31.1K ﹤0.01% 2413
2018
Q2 		$643K Buy
17,200
+16,900
+5,633% +$571K ﹤0.01% 2574
2018
Q1 		$9K Sell
300
-600
-67% -$20.3K ﹤0.01% 4366
2017
Q4 		$30 Sell
900
-6,500
-88% -$219K ﹤0.01% 4123
2017
Q3 		$268 Sell
7,400
-30,100
-80% -$859K ﹤0.01% 3007
2017
Q2 		$969 Buy
37,500
+31,800
+558% +$675K 0.01% 1806
2017
Q1 		$110 Sell
5,700
-194,300
-97% -$3.44M ﹤0.01% 3348
2016
Q4 		$3.33M Buy
+200,000
New +$3.62M 0.02% 634
2016
Q3 		– Sell
-29,900
Closed -$915K – 5221
2016
Q2 		$915K Buy
+29,900
New +$1.04M 0.01% 1680
2016
Q1 		– Sell
-1,500
Closed -$64K – 5669
2015
Q4 		$64K Sell
1,500
-69,700
-98% -$2.94M ﹤0.01% 3667
2015
Q3 		$2.67M Buy
71,200
+70,100
+6,373% +$2.49M 0.02% 509
2015
Q2 		$37K Buy
+1,100
New +$37.4K ﹤0.01% 3668
2014
Q3 		– Sell
-600
Closed -$23 – 4268
2014
Q2 		$23 Buy
+600
New +$22.3K ﹤0.01% 3178
2013
Q3 		– Sell
-88,900
Closed -$2.39M – 3124
2013
Q2 		$2.39M Buy
+88,900
New +$2.58M 0.02% 511

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Walleye Trading's MYGN Position: Q3 2022 in Review

Walleye Trading sold out of Myriad Genetics (MYGN) in Q3 2022, closing a stake of 12,446 shares — an estimated $226K sold.

Walleye Trading first reported a position in MYGN in Q2 2013 and held it in 17 quarters. The position peaked at $1.36M in Q3 2015. 191 funds tracked by Wall St. Rank hold MYGN as of Q3 2022.

  • Walleye Trading reported no remaining Myriad Genetics position as of Q3 2022 after selling out during the quarter.
  • Walleye Trading sold 12,446 Myriad Genetics shares in Q3 2022, an estimated $226K.
  • Walleye Trading first reported a position in Myriad Genetics in Q2 2013 and held it in 17 quarters.
  • Walleye Trading's Myriad Genetics position peaked at $1.36M in Q3 2015.
  • 191 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2022.

Based on Walleye Trading's 13F filing for Q3 2022, filed 14 Nov 2022.